Composition:
Each tablet of Lapatinib 250 mg contains 250 mg of Lapatinib as the active ingredient.
Description:
HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medication Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients.
Lapatinib 250 mg is mainly prescribed for the treatment of:
Share your experience with our medical product. Write a review!
25 Apr 2026
World Liver Day 2026: Signs, Causes & How to Protect Your Liver Naturally
The liver is one of the most vital organs in the human body, responsible for detoxification, metabolism, and nutrient storage. Yet, liver health is often overlooked until symptoms become serious.
15 Apr 2026
World Health Day 2026: Small Health Habits That Prevent Big Diseases
Every year, World Health Day reminds us of something very simple yet powerful-our health deserves attention every single day, not only when something goes wrong. World Health Day 2026 is a good moment
25 Mar 2026
Transdermal Patches 2026: Latest Trends, Benefits & How They’re Revolutionizing Pain & Nicotine Relief
Transdermal patches are advanced drug delivery systems that deliver medication through the skin directly into the bloodstream. In 2026, new health technology trends are making transdermal patches more
14 Mar 2026
How Carica Papaya Leaf Extract Supports Platelet Recovery: Evidence, Uses & Best Practices
A healthy platelet count is essential for proper clotting, immune defense, and overall blood health. When platelet levels fall below normal-commonly referred to as low platelet count-the body becomes
